Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

NexMR GmbH

NexMR GmbH is an innovative technology company dedicated to revolutionizing fragment-based drug discovery. Leveraging advanced nuclear magnetic resonance (NMR) techniques, NexMR provides efficient solutions for fragment screening and lead optimization. Their cutting-edge platform enables researchers to accelerate the development of novel therapeutics. *


Period Start 2022-05-31 established (s-off)
  Predecessor ETH Zürich (ETHZ)
Products Industry drug discovery technology
  Industry 2 NMR spectroscopy
Person Person Torres Hubiche, Félix (NexMR 202307 CEO + Co-Founder)
Region Region Schlieren ZH
  Country Switzerland
  Street 10A Wiesenstr.
  City 8952 Schlieren ZH
    Address record changed: 2023-12-19
Basic data Employees n. a.
    * Document for »About Section«: CrystalsFirst GmbH. (7/24/23). "Press Release: CrystalsFirst and NexMR Join Forces to Supercharge Fragment-based Drug Discovery".
Record changed: 2023-12-19


Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for NexMR GmbH

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group World of Partnering Opportunities 650x300px

» top